3,316
Views
22
CrossRef citations to date
0
Altmetric
research paper

Berberine inhibited carotid atherosclerosis through PI3K/AKTmTOR signaling pathway

&
Pages 8135-8146 | Received 11 May 2021, Accepted 24 Sep 2021, Published online: 21 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yingjie Liu, Gang Luo, Quan Tang, Yang Song, Daxing Liu, Hongjuan Wang & Junliang Ma. (2022) Methyltransferase-like 14 silencing relieves the development of atherosclerosis via m6A modification of p65 mRNA. Bioengineered 13:5, pages 11832-11843.
Read now
Dan Wu, Haizhe Ji, Wenjuan Du, Lina Ren & Geng Qian. (2022) Mitophagy alleviates ischemia/reperfusion-induced microvascular damage through improving mitochondrial quality control. Bioengineered 13:2, pages 3596-3607.
Read now

Articles from other publishers (20)

Xiaoli Yang, Chenglin Chi, Wenjing Li, Yanyan Zhang, Shufang Yang, Ruoxuan Xu & Rongxia Liu. (2024) Metabolomics and lipidomics combined with serum pharmacochemistry uncover the potential mechanism of Huang-Lian-Jie-Du decoction alleviates atherosclerosis in ApoE−/− mice. Journal of Ethnopharmacology 324, pages 117748.
Crossref
Zhi-Xiang Zhou, Xiao-Feng Ma, Wen-Hao Xiong, Zhong Ren, Miao Jiang, Nian-Hua Deng, Bo-Bin Zhou, Hui-Ting Liu, Kun Zhou, Heng-Jing Hu, Hui-Fang Tang, He Zheng & Zhi-Sheng Jiang. (2024) TRIM65 promotes vascular smooth muscle cell phenotypic transformation by activating PI3K/Akt/mTOR signaling during atherogenesis. Atherosclerosis 390, pages 117430.
Crossref
Mohammad Rafi Khezri, Somayeh Mohammadipanah & Morteza Ghasemnejad‐Berenji. (2023) The pharmacological effects of Berberine and its therapeutic potential in different diseases: Role of the phosphatidylinositol 3‐kinase/ AKT signaling pathway . Phytotherapy Research 38:1, pages 349-367.
Crossref
Yilin Chen, Fengwei Zhang, Jijia Sun & Lei Zhang. (2023) Identifying the natural products in the treatment of atherosclerosis by increasing HDL-C level based on bioinformatics analysis, molecular docking, and in vitro experiment. Journal of Translational Medicine 21:1.
Crossref
Jingqi Li, Qi Zhang, Yutong Chen, Chengyu Lu & Yongbin Tong. (2023) Pharmacokinetics, Tissue Distribution and Excretion of Demethyleneberberine, a Metabolite of Berberine, in Rats and Mice. Molecules 28:23, pages 7725.
Crossref
Yajie Cai, Qiaoning Yang, Yanqiao Yu, Furong Yang, Ruina Bai & Xiaodi Fan. (2023) Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review. Frontiers in Pharmacology 14.
Crossref
Dongyang Zhao, Kaijing Guo, Qian Zhang, Yan Wu, Chen Ma, Wenyi He, Xiangju Jin, Xinyu Zhang, Yanan Wang, Sheng Lin & Hongcai Shang. (2023) Mechanism of XiJiaQi in the treatment of chronic heart failure: Integrated analysis by pharmacoinformatics, molecular dynamics simulation, and SPR validation. Computers in Biology and Medicine 166, pages 107479.
Crossref
Li Chen, Meng Tian, Jing Yang & Zhenxu Wu. (2023) Berberine-Encapsulated Poly(lactic-co-glycolic acid)–Hydroxyapatite (PLGA/HA) Microspheres Synergistically Promote Bone Regeneration with DOPA-IGF-1 via the IGF-1R/PI3K/AKT/mTOR Pathway. International Journal of Molecular Sciences 24:20, pages 15403.
Crossref
Pengfei Li, Hongyu LiXiaohui LiShuangdi LiHanying XuJunfeng CuiGuangyu Cheng, Yinghui LiuXiaolin XuYuning XinAidong Liu. (2023) San Jie Tong Mai Fang Protects Against Atherosclerosis Progression by Regulating Macroautophagy through the PI3K/AKT/mTOR Signaling Pathway. Journal of Cardiovascular Pharmacology 82:4, pages 333-343.
Crossref
Yao Wang, Lili Liu, Cheng Cheng, Shuxuan Wang, Qirui Zhai, Yunyang Song & Ronghua Dai. (2023) Study on mechanism of Zishen Pill treating benign prostatic hyperplasia based on serum pharmacochemistry and network pharmacology. Journal of Pharmaceutical and Biomedical Analysis 234, pages 115480.
Crossref
Guixia Shi, Lixiong Zeng, Jialu Shi & Yunhua Chen. (2023) Trimethylamine N-oxide Promotes Atherosclerosis by Regulating Low-Density Lipoprotein-Induced Autophagy in Vascular Smooth Muscle Cells Through PI3K/AKT/mTOR Pathway. International Heart Journal 64:3, pages 462-469.
Crossref
Xiaoyu Xuan, Jingyi Zhang, Jilin Fan & Shiliang Zhang. (2023) Research progress of Traditional Chinese Medicine (TCM) in targeting inflammation and lipid metabolism disorder for arteriosclerosis intervention: A review. Medicine 102:18, pages e33748.
Crossref
Xi Xu, Baigao Yang, Hang Zhang, Xiaoyi Feng, Haisheng Hao, Weihua Du, Huabin Zhu, Adnan Khan, Muhammad Zahoor Khan, Peipei Zhang & Xueming Zhao. (2023) Effects of β-Nicotinamide Mononucleotide, Berberine, and Cordycepin on Lipid Droplet Content and Developmental Ability of Vitrified Bovine Oocytes. Antioxidants 12:5, pages 991.
Crossref
Zhou Liang, Xinrong Hu, Ruoni Lin, Ziwen Tang, Ziyin Ye, Ren Mao, Wei Chen & Yi Zhou. (2023) Identification of shared gene signatures and molecular mechanisms between chronic kidney disease and ulcerative colitis. Frontiers in Immunology 14.
Crossref
Qian Wu, Qianyu Lv, Xiao’an Liu, Xuejiao Ye, Linlin Cao, Manshi Wang, Junjia Li, Yingtian Yang, Lanlan Li & Shihan Wang. (2023) Natural compounds from botanical drugs targeting mTOR signaling pathway as promising therapeutics for atherosclerosis: A review. Frontiers in Pharmacology 14.
Crossref
Jie Zhang, Xinyi Wang, Baoyi Guan, Xue Wang, Xiaojing An, Tong Wang, Xuanye Chen, Lin Zhao, Jundi Jia, Luxia Song, Dan Ma, Qiuyi Li, He Zhang, Jianqing Ju & Hao Xu. (2023) Qing-Xin-Jie-Yu Granule inhibits ferroptosis and stabilizes atherosclerotic plaques by regulating the GPX4/xCT signaling pathway. Journal of Ethnopharmacology 301, pages 115852.
Crossref
Yifei Lv, Hongfeng Yang, Peng Ye, Zhiyuan Qian, Dongchen Wang, Chaohua Kong, Yue Gu, Wenying Zhou, Shaoliang Chen & Linlin Zhu. (2022) Berberine inhibits low shear stress-induced vascular endothelial inflammation via decreasing phosphorylation of Akt and IRF3. Tissue and Cell 79, pages 101946.
Crossref
Tianwei Meng, Xinghua Li, Chengjia Li, Jiawen Liu, Hong Chang, Nan Jiang, Jiarui Li, Yabin Zhou & Zhiping Liu. (2022) Natural products of traditional Chinese medicine treat atherosclerosis by regulating inflammatory and oxidative stress pathways. Frontiers in Pharmacology 13.
Crossref
Yang Fu, Jian-wei Liu, Ji Wu, Zu-xiang Wu, Juan Li, Hui-fang Ji, Ning-peng Liang, Hong-jin Zhang, Ze-qun Lai & Yi-Fei Dong. (2022) Inhibition of semaphorin-3a alleviates lipopolysaccharide-induced vascular injury. Microvascular Research 142, pages 104346.
Crossref
Richard Y. Cao, Ying Zhang, Zhen Feng, Siyu Liu, Yifan Liu, Hongchao Zheng & Jian Yang. (2021) The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis. Frontiers in Pharmacology 12.
Crossref